Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.
Related Items
Web Exclusives published on December 9, 2021 in ASCO, Biliary Tract Cancer, Cholangiocarcinoma, Pancreatic Cancer
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
2020 Year in Review - Lung Cancer published on January 20, 2021 in Lung Cancer
Last modified: July 22, 2021
